1. Home
  2. CUZ vs ABVX Comparison

CUZ vs ABVX Comparison

Compare CUZ & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUZ
  • ABVX
  • Stock Information
  • Founded
  • CUZ 1958
  • ABVX 2013
  • Country
  • CUZ United States
  • ABVX France
  • Employees
  • CUZ N/A
  • ABVX N/A
  • Industry
  • CUZ Real Estate Investment Trusts
  • ABVX
  • Sector
  • CUZ Real Estate
  • ABVX
  • Exchange
  • CUZ Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • CUZ 5.0B
  • ABVX 5.3B
  • IPO Year
  • CUZ N/A
  • ABVX N/A
  • Fundamental
  • Price
  • CUZ $29.49
  • ABVX $83.97
  • Analyst Decision
  • CUZ Buy
  • ABVX Buy
  • Analyst Count
  • CUZ 9
  • ABVX 8
  • Target Price
  • CUZ $32.22
  • ABVX $79.50
  • AVG Volume (30 Days)
  • CUZ 1.5M
  • ABVX 1.2M
  • Earning Date
  • CUZ 10-23-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • CUZ 4.32%
  • ABVX N/A
  • EPS Growth
  • CUZ N/A
  • ABVX N/A
  • EPS
  • CUZ 0.37
  • ABVX N/A
  • Revenue
  • CUZ $917,942,000.00
  • ABVX $7,073,400.00
  • Revenue This Year
  • CUZ $13.63
  • ABVX $25.23
  • Revenue Next Year
  • CUZ $3.36
  • ABVX N/A
  • P/E Ratio
  • CUZ $79.81
  • ABVX N/A
  • Revenue Growth
  • CUZ 11.98
  • ABVX N/A
  • 52 Week Low
  • CUZ $24.07
  • ABVX $4.77
  • 52 Week High
  • CUZ $32.55
  • ABVX $92.91
  • Technical
  • Relative Strength Index (RSI)
  • CUZ 61.39
  • ABVX 66.79
  • Support Level
  • CUZ $28.61
  • ABVX $82.72
  • Resistance Level
  • CUZ $29.82
  • ABVX $91.30
  • Average True Range (ATR)
  • CUZ 0.54
  • ABVX 3.62
  • MACD
  • CUZ 0.08
  • ABVX -1.16
  • Stochastic Oscillator
  • CUZ 87.29
  • ABVX 45.43

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: